The Prevalence and Management of Atrial Fibrillation in New Zealand Māori Detected through an Abdominal Aortic Aneurysm Screening Program
Heart, Lung and Circulation · 2024
DOI: 10.1016/j.hlc.2023.09.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heart, Lung and Circulation, 2024. Verfasst von Peter Sandiford und 7 weiteren Autor:innen. Beteiligte Einrichtung: Planning Funding and Outcomes, Auckland and Waitematā District Health Boards, Auckland, New Zealand. Electronic address: peter.sandiford@waitematadhb…. Hauptthemen laut MEDLINE: Aortic Aneurysm, Abdominal, Atrial Fibrillation, Brain Ischemia, Stroke. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Atrial fibrillation (AF) screening was incorporated into an abdominal aortic aneurysm screening (AAA) program for New Zealand (NZ) Māori. METHODS: AF screening was performed as an adjunct to AAA screening of Māori men aged 60-74 years and women aged 65-74 years registered with primary health care practices in Auckland, NZ. Pre-existing AF was determined through coded diagnoses or medications in the participant's primary care record. Subsequent audit of the record assessed accuracy of pre-screening coding, medication use and clinical follow-up. RESULTS: Among 1,933 people successfully screened, the prevalence of AF was 144 (7.4%), of which 46 (2.4% of the cohort) were patients without AF coded in the medical record. More than half of these were revealed to be known AF but that was not coded. Thus, the true prevalence of newly detected AF was 1.1% (n=21). An additional 48 (2.5%) of the cohort had been coded as AF but were not in AF at the time of screening. Among the 19 at-risk screen-detected people with AF, 10 started appropriate anticoagulation therapy within 6 months. Of the nine patients who did not commence anticoagulation therapy, five had a subsequent adverse clinical outcome in the follow-up period, including one with ischaemic stroke; two had contraindications to anticoagulants. Among those with previously diagnosed AF, the proportion receiving anticoagulation therapy rose from 57% pre-screening to 83% at 6 months post-screening (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Planning Funding and Outcomes, Auckland and Waitematā District Health Boards, Auckland, New Zealand. Electronic address: peter.sandiford@waitematadhb.govt.nz.
- Faculty of Medicine, University of Auckland, Auckland, New Zealand.
- Planning Funding and Outcomes, Auckland and Waitematā District Health Boards, Auckland, New Zealand.
- Auckland City Hospital, Auckland, New Zealand.
Zitieren
APA
Sandiford, P., Poppe, K. K., Grey, C., Doughty, R., Chambers, E., Kim, K. J., Hill, A., & Bartholomew, K. (2024). The Prevalence and Management of Atrial Fibrillation in New Zealand Māori Detected through an Abdominal Aortic Aneurysm Screening Program. Heart, Lung and Circulation. https://doi.org/10.1016/j.hlc.2023.09.025
Vancouver
Sandiford P, Poppe KK, Grey C, Doughty R, Chambers E, Kim KJ, et al. The Prevalence and Management of Atrial Fibrillation in New Zealand Māori Detected through an Abdominal Aortic Aneurysm Screening Program. Heart, Lung and Circulation. 2024. doi:10.1016/j.hlc.2023.09.025
BibTeX
@article{Sandiford2024,
author = {Sandiford, Peter and Poppe, Katrina K and Grey, Corina and Doughty, Robert and Chambers, Erin and Kim, Kyu J and Hill, Andrew and Bartholomew, Karen},
title = {The Prevalence and Management of Atrial Fibrillation in New Zealand Māori Detected through an Abdominal Aortic Aneurysm Screening Program},
journal = {Heart, Lung and Circulation},
year = {2024},
doi = {10.1016/j.hlc.2023.09.025}
}
EUVIMED